DERL3 and nonpapillary renal cell carcinoma: In summary, our research further confirms the crucial role of DERL3 in ccRCC metastasis, elucidates the underlying molecular mechanisms of ccRCC progression, and emphasizes the potential of DERL3 as a novel therapeutic target for this disease.